This advice sets out where and when it may be appropriate to prescribe liothyronine in the NHS for current and new patients with hypothyroidism, depression and thyroid cancer. It supports the safe, appropriate and cost-effective use of liothyronine to achieve the best outcomes for patients and ensure effective use of NHS resources.